The detailed analysis, including subgroup breakdowns, long-term safety data, and secondary endpoints, takes additional months to compile
do not discontinue without consulting your provider Monitor blood glucose regularly and report persistent hyperglycemia Test for ketones if nausea, vomiting, or abdominal pain occur Stay hydrated to reduce risk of dehydration and kidney injury Follow up with HbA1C tests every 36 months Drug interactions Diuretics: increased risk of dehydration and hypotension Insulin or sulfonylureas: increased hypoglycemia risk ACE inhibitors and NSAIDs: potential for worsened renal function Sources Farxiga (dapagliflozin) tablets, for oral use [package insert]
For what other conditions have GLP-1 drugs been studied
At Marken, we start by utilizing the best performance packaging to maintain stability, whether it be high-performance insulation or incorporating containers with phase change materials to absorb and release heat for stabilizing the desired temperature
1961 obese, non-diabetic participants lost approximately 15% of their body weight over 68 weeks with once-weekly 2.4 mg injectable Semaglutide, alongside lifestyle changes